30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Robert LeBuhn

Track

Insider profile

Performance

Overall performance
3.4
Performance over holding periods
3.4
30 days 90 days 120 days
Average return -0% 8.2% 15.1%
Success rate 58% 68% 82%
Transactions
9 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Enzon Pharmaceuticals Inc Aug. 1, 1994 - Oct. 8, 2013
Robert LeBuhn's trades of Enzon Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2013-09-19 2013-09-19
S Sale
35,342 -31.3%
348.50
US$1,955,855 		35,342 -31.3% 348.50 US$1,955,855
2013-09-19 2013-09-17
S Sale
94,900 -17.1%
489.34
US$1,377,719 		94,900 -17.1% 489.34 US$1,377,719
2012-08-15 2012-08-14
S Sale
24,357 +21.6%
28.10
US$4,439,187 		24,357 +21.6% 28.10 US$4,439,187
2012-08-13 2012-08-10
S Sale
1,933 -1.8%
6.58
US$12,720 		1,933 -1.8% 6.58 US$12,720
2011-06-02 2011-06-01
S Sale
8,702
10.57
US$91,980 		8,702 10.57 US$91,980
2011-02-24 2011-02-22
S Sale
10,000 -9.4%
10.88
US$108,817 		10,000 -9.4% 10.88 US$108,817
2010-08-27 2010-08-26
S Sale
5,000 -4.5%
10.49
US$52,425 		5,000 -4.5% 10.49 US$52,425
2010-08-27 2010-08-26
S Sale
400 -0.4%
10.51
US$4,204 		400 -0.4% 10.51 US$4,204
2010-08-27 2010-08-26
S Sale
4,600 -3.9%
10.50
US$48,300 		4,600 -3.9% 10.50 US$48,300